Highlights

  • Govt: remdesivir not to be used in home settings
  • Tocilizumab may be considered in case of severe infection: Govt
  • SpO2 lower than 90% to be considered as severe disease: Govt guidelines

Latest news

On cam: driver, passengers thrown off seats as two buses collide in Tamil Nadu

On cam: driver, passengers thrown off seats as two buses collide in Tamil Nadu

US spies show UFO videos at Congressional hearing on increasing encounters. Watch what Pentagon revealed

US spies show UFO videos at Congressional hearing on increasing encounters. Watch what Pentagon revealed

Cannes 2022: Deepika Padukone graces the red carpet in a retro look

Cannes 2022: Deepika Padukone graces the red carpet in a retro look

Amid scorching heat, students made to study in the sun in Moradabad

Amid scorching heat, students made to study in the sun in Moradabad

Priyanka Chopra leaves fans worried with pic of her bruised face

Priyanka Chopra leaves fans worried with pic of her bruised face

Govt issues new guidelines for Covid-19 treatment. Here's all you need to know

The new guidelines issued by AIIMS and ICMR stated that anti-inflammatory or immunomodulatory therapy like steroids carry the risk of secondary infection like invasive mucormycosis. 

COVID-19 Treatment Guidelines: The Centre on Monday issued renewed guidelines for effective treatment of Covid-19.

The new guidelines issued by All India Institute Of Medical Science(AIIMS) and Indian Council of Medical Research (ICMR) stated that anti-inflammatory or immunomodulatory therapy like steroids carries the risk of secondary infection like invasive mucormycosis when used too early, at higher dose, or for longer than required.

The revised guidelines continue to recommend emergency use authorization (EUA) or off-label use of remdesivir in patients with “moderate to severe” disease and those with no renal or hepatic dysfunction within 10 days of the onset of any symptom.

It warned against use of the drug for patients who are not on oxygen support or in home settings.

According to the guidelines, emergency use or off-label use of the tocilizumab drug may be considered in the presence of severe disease, preferably within 24 to 48 hours of onset of severe disease or intensive care unit (ICU) admission.

According to the guidance note, upper respiratory tract symptoms without shortness of breath or hypoxia has been categorised as mild disease and such patients have been advised home isolation and care.

Also watch: Govt says no to mandatory Covid-19 vaccination but can inoculation be forced in India?

Those suffering from mild Covid should seek medical attention if they have difficulty in breathing, high grade fever, or severe cough lasting for more than five days.

Those having breathlessness with SpO2 fluctuating between 90-93 per cent, can get admitted to a ward, and they will be considered moderate cases.

Such patients should be given oxygen support and awake proning should be encouraged in all patients requiring supplemental oxygen therapy.

Respiratory rate over 30 per minute, breathlessness or SpO2 lower than 90 per cent on room air should be considered as severe disease and such patients have to be admitted to an ICU as they will need respiratory support.

Also Read: India's Covid-19 vaccination drive completes a year: here are the major takeaways

Up Next

Govt issues new guidelines for Covid-19 treatment. Here's all you need to know

Govt issues new guidelines for Covid-19 treatment. Here's all you need to know

Amid scorching heat, students made to study in the sun in Moradabad

Amid scorching heat, students made to study in the sun in Moradabad

Delhi L-G resigns: Anil Baijal cited 'personal reasons' to quit, say reports

Delhi L-G resigns: Anil Baijal cited 'personal reasons' to quit, say reports

Punjab farmers call off protest but what prompted them to take to the streets

Punjab farmers call off protest but what prompted them to take to the streets

23.5 lakh premature deaths in India due to pollution in 2019: Lancet

23.5 lakh premature deaths in India due to pollution in 2019: Lancet

Will India deploy Russian S-400 missile defence next month: here's what US intelligence thinks

Will India deploy Russian S-400 missile defence next month: here's what US intelligence thinks

More videos

Terror attack on liquor shop in Kashmir's Baramulla, attackers caught on camera

Terror attack on liquor shop in Kashmir's Baramulla, attackers caught on camera

Raj Thackeray's MNS calls for demolition of Aurangzeb's tomb, security beefed up

Raj Thackeray's MNS calls for demolition of Aurangzeb's tomb, security beefed up

Cannes 2022: Mame Khan is the first Indian folk artist to walk the red carpet

Cannes 2022: Mame Khan is the first Indian folk artist to walk the red carpet

‘Shivling’ claim: Explained how information on Gyanvapi mosque survey was leaked

‘Shivling’ claim: Explained how information on Gyanvapi mosque survey was leaked

₹10,000 fine for Twitter blue tick case: CBI ex-chief pulled up by Delhi High Court for repeated pleas

₹10,000 fine for Twitter blue tick case: CBI ex-chief pulled up by Delhi High Court for repeated pleas

Terror attack on liquor shop in Kashmir: Jammu local killed; BJP blames new terror outfit JKFF

Terror attack on liquor shop in Kashmir: Jammu local killed; BJP blames new terror outfit JKFF

Fight at marriage hall in UP's Moradabad, video goes viral: watch what happened

Fight at marriage hall in UP's Moradabad, video goes viral: watch what happened

USA preparing military aid package for India, says report

USA preparing military aid package for India, says report

Terrorists release video on Vaishno Devi pilgrim bus attack, warn of more strikes ahead of Amarnath Yatra

Terrorists release video on Vaishno Devi pilgrim bus attack, warn of more strikes ahead of Amarnath Yatra

Chaos at Smriti Irani's meet, attack on woman NCP worker on cam; 3 BJP cadre booked

Chaos at Smriti Irani's meet, attack on woman NCP worker on cam; 3 BJP cadre booked

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.